Compounds > glucose, (beta-d)-isomer
Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Electrocardiogram QT Prolonged

glucose, (beta-d)-isomer has been researched along with Electrocardiogram QT Prolonged in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dinçsoy, B; Erdemb, A; Gedikli, E; Özgür Barış, V1
Brand, T; Breithaupt-Groegler, K; Broedl, UC; Macha, S; Ring, A; Simons, G; Walter, B; Woerle, HJ1

Trials

1 trial(s) available for glucose, (beta-d)-isomer and Electrocardiogram QT Prolonged

ArticleYear
The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study.
    Cardiovascular diabetology, 2013, Apr-24, Volume: 12

    Topics: Action Potentials; Adolescent; Adult; Benzhydryl Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Germany; Glucosides; Heart Conduction System; Heart Rate; Humans; Hypoglycemic Agents; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Risk Assessment; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Young Adult

2013

Other Studies

1 other study(ies) available for glucose, (beta-d)-isomer and Electrocardiogram QT Prolonged

ArticleYear
Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.
    Kardiologia polska, 2021, 01-25, Volume: 79, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Benzhydryl Compounds; Electrocardiography; Glucosides; Humans; Long QT Syndrome; Rats; Sotalol

2021